» Articles » PMID: 17521938

Energizing MiRNA Research: a Review of the Role of MiRNAs in Lipid Metabolism, with a Prediction That MiR-103/107 Regulates Human Metabolic Pathways

Overview
Journal Mol Genet Metab
Specialty Endocrinology
Date 2007 May 25
PMID 17521938
Citations 151
Authors
Affiliations
Soon will be listed here.
Abstract

MicroRNAs (miRNAs) are powerful regulators of gene expression. Although first discovered in worm larvae, miRNAs play fundamental biological roles-including in humans-well beyond development. MiRNAs participate in the regulation of metabolism (including lipid metabolism) for all animal species studied. A review of the fascinating and fast-growing literature on miRNA regulation of metabolism can be parsed into three main categories: (1) adipocyte biochemistry and cell fate determination; (2) regulation of metabolic biochemistry in invertebrates; and (3) regulation of metabolic biochemistry in mammals. Most research into the 'function' of a given miRNA in metabolic pathways has concentrated on a given miRNA acting upon a particular 'target' mRNA. Whereas in some biological contexts the effects of a given miRNA:mRNA pair may predominate, this might not be the case generally. In order to provide an example of how a single miRNA could regulate multiple 'target' mRNAs or even entire human metabolic pathways, we include a discussion of metabolic pathways that are predicted to be regulated by the miRNA paralogs, miR-103 and miR-107. These miRNAs, which exist in vertebrate genomes within introns of the pantothenate kinase (PANK) genes, are predicted by bioinformatics to affect multiple mRNA targets in pathways that involve cellular Acetyl-CoA and lipid levels. Significantly, PANK enzymes also affect these pathways, so the miRNA and 'host' gene may act synergistically. These predictions require experimental verification. In conclusion, a review of the literature on miRNA regulation of metabolism leads us believe that the future will provide researchers with many additional energizing revelations.

Citing Articles

Complex p53 dynamics regulated by miR-125b in cellular responses to reactive oxidative stress and DNA damage.

Malik M, Dashti M, Jangid A, Channanath A, John S, Brojen Singh R Brief Bioinform. 2025; 26(1.

PMID: 39820247 PMC: 11736902. DOI: 10.1093/bib/bbae706.


Mast cell-mediated microRNA functioning in immune regulation and disease pathophysiology.

Deng Q, Yao X, Fang S, Sun Y, Liu L, Li C Clin Exp Med. 2025; 25(1):38.

PMID: 39812911 PMC: 11735496. DOI: 10.1007/s10238-024-01554-2.


Association of MicroRNA-103 expression with type 2 diabetes mellitus.

Rafiee M, Sadeghi F, Mirzapour A, Khafri S, Korani B, Al-E-Ahmad A Caspian J Intern Med. 2024; 16(1):106-113.

PMID: 39619764 PMC: 11607116. DOI: 10.22088/cjim.16.1.106.


Oligonucleotide therapies for nonalcoholic steatohepatitis.

Li S, Xiong F, Zhang S, Liu J, Gao G, Xie J Mol Ther Nucleic Acids. 2024; 35(2):102184.

PMID: 38665220 PMC: 11044058. DOI: 10.1016/j.omtn.2024.102184.


Extracellular vesicles and exosome-like nanovesicles as pioneering oral drug delivery systems.

Mondal J, Pillarisetti S, Junnuthula V, Surwase S, Hwang S, Park I Front Bioeng Biotechnol. 2024; 11:1307878.

PMID: 38260737 PMC: 10800420. DOI: 10.3389/fbioe.2023.1307878.


References
1.
Mersey B, Jin P, Danner D . Human microRNA (miR29b) expression controls the amount of branched chain alpha-ketoacid dehydrogenase complex in a cell. Hum Mol Genet. 2005; 14(22):3371-7. DOI: 10.1093/hmg/ddi368. View

2.
Marsit C, Eddy K, Kelsey K . MicroRNA responses to cellular stress. Cancer Res. 2006; 66(22):10843-8. DOI: 10.1158/0008-5472.CAN-06-1894. View

3.
Cullen B . Transcription and processing of human microRNA precursors. Mol Cell. 2004; 16(6):861-5. DOI: 10.1016/j.molcel.2004.12.002. View

4.
Kim V . Small RNAs: classification, biogenesis, and function. Mol Cells. 2005; 19(1):1-15. View

5.
Hurst L . Preliminary assessment of the impact of microRNA-mediated regulation on coding sequence evolution in mammals. J Mol Evol. 2006; 63(2):174-82. DOI: 10.1007/s00239-005-0273-2. View